Levels of insulin autoantibodies (IAA) vary among different first degree relatives of insulin-dependent diabetes mellitus patients, suggesting genetic regulation. We previously reported elevated IAA among DR4-positive at risk relatives. In this study, 72/82 at risk relatives were IAA positive, of whom 75% (54/72) carried DR4 versus 20% (2/10) of IAA-negative relatives (P = 0.0004). However, 69% (18/26) of DR4-negative relatives were IAA positive. Since DR4 did not account for all IAA positivity, we analyzed DQA1 and DQB1 alleles. Homozygosity for DQA1 alleles deriving from the evolutionary lineage 4 (*0401, *0501, *0601) was associated with low IAA levels, while lineage 1-3 alleles (*0101, *0102, *0103, *0201, *0301) correlated with higher levels. Most (93%, 65/70) relatives with lineage 1-3 alleles were IAA positive (mean = 360±63 SEM nU/ml). Only 7/12 relatives homozygous for lineage 4 alleles were IAA-positive, with lower levels than relatives with lineage 1-3 alleles (mean = 55±15 SEM nU/ml, P < 0.0001; 7/12 vs 65 /70, P = 0.004). The amino acid sequences of lineage 1-3 alleles uniquely share glutamic acid (E) and phenylalanine (F) at positions 40 and 51 (EF alleles). Lineage 4 alleles have glycine (G) and leucine (L) at those positions (GL alleles). 90% (65/72) of IAA-positive relatives had an EF allele, while only 75% (54/72) had DR4 (P = 0.01). Homozygosity for GL alleles (often DQA1 *0501 on DR3 haplotypes) correlated with little or no humoral response to insulin. Thus, HLA-DQB1 GL alleles, or other genes on haplotypes (e.g., DR3) that carry these DQA1 alleles, may confer recessive low responsiveness to insulin. (J. Clin. Invest. 1994.93:2447-2452 the autoimmune response, and autoantibodies against these molecules are detectable in the sera of most prediabetics or newly diagnosed IDDM patients (1, 2). It is still not known if there is a precise pattern of humoral autoimmunity leading to IDDM, and indeed we are learning that different individuals may have a different combination of autoantibodies with a different order of appearance during the prediabetic period. The heterogeneity of the autoimmune process may be in part determined by genetic factors.
the autoimmune response, and autoantibodies against these molecules are detectable in the sera of most prediabetics or newly diagnosed IDDM patients (1, 2) . It is still not known if there is a precise pattern of humoral autoimmunity leading to IDDM, and indeed we are learning that different individuals may have a different combination of autoantibodies with a different order of appearance during the prediabetic period. The heterogeneity of the autoimmune process may be in part determined by genetic factors.
Among the target autoantigens, insulin is the only ( cellspecific autoantigen identified to date, and thus immune responsiveness to this molecule may have an important role in the autoimmune process (4, 5) . We have reported an inverse log-linear correlation between insulin autoantibody (IAA) levels and the age of diabetes onset, with the highest levels found in children who became diabetic before age 5 (6) . Autoantibody-positive relatives of IDDM patients have different levels of IAA. Individual levels of IAA are often stable over long periods of time, changing very little during the prediabetic period (7). These observations suggest that the extent of the immune response to insulin may be at least in part genetically determined. Indeed, we have previously reported a significant association of high levels of IAA with HLA-DR4 haplotypes (8) . However, DR4 did not account for all the individuals with high IAA levels.
The aim of our study was to further characterize HLA alleles associated with the humoral response to insulin during the prediabetic period in 82 first degree relatives at risk for IDDM, who were defined at risk if they were either IAA or islet cell antibody (ICA) positive or because they developed IDDM on follow-up regardless of their autoantibody status.
We find evidence that two different subsets ofDQA 1 alleles derived from evolutionary lineages 1-3 and 4 (9, 10) are associated with phenotypic variation in levels ofIAA. In particular, homozygosity for lineage 4 alleles (including DQA1*0501 found on DR3 and DR5 haplotypes, as well as the much rarer *0401 and *0601) is associated with low levels of IAA. In contrast, lineage 1-3 DQA 1 alleles (including DQA 1 *0301 found on DR4 haplotypes) are associated with high levels of IAA. Of note, only lineage 1-3 DQA1 alleles carry glutamic acid at position 40 and phenylalanine at position 51 of their second exon. Therefore, the presence of these residues is shared only by those DQA 1 alleles associated with high IAA levels both on DR4 and non-DR4 haplotypes. Our data lead us to speculate that these DQA 1 sequences shared by lineage 1-3 alleles may facilitate the presentation of insulin to the immune system and determine higher levels of autoantibodies once tolerance to insulin is broken during the prediabetic period.
Methods
IAA and ICA assays. IAA was measured by a competitive radioimmunoassay as described previously (6). Our upper limit of normal is 39 nU/ml (3 SD above normal). Reported IAA values represent the indi-vidual mean level ofseveral autoantibody measurements before insulin therapy. ICA was determined as reported previously ( I1 ) including the restricted and nonrestricted subtypes ( 12) . According to this classification, relatives with restricted ICA have a lower risk of diabetes compared with relatives with nonrestricted ICA. However, three relatives with restricted ICA were included in this analysis, since one of them became diabetic on follow-up at age 68, and the other two had elevated IAA levels.
Subjects. After cytoplasmic ICA and IAA screening of -6,000 first degree relatives ofIDDM patients, we have analyzed the HLA type and IAA level of 82 individuals at increased risk for IDDM. Subjects were defined at risk for IDDM if they had one or a combination of the following: (a) they had nonrestricted ICA > 20 JDF units; (b) they had been followed to the development of overt IDDM; and (c) they had a mean IAA level > 39 nU/ml in the absence ofother antiislet autoantibodies. Table I illustrates the autoantibody status of the above 82 relatives subdivided by progression to overt diabetes. 72 of 82 relatives had IAA levels > 39 nU/ml, of which 40 were ICA positive, and 32 were ICA negative. 49 relatives were ICA positive (46 had nonrestricted ICA, and 3 had restricted ICA). Ofthe 34 (41.4%) relatives who became diabetic on follow-up, 20 
Results
The majority (87.8%, 72/82) of first degree relatives at risk for diabetes had IAA levels > 39 nU/ml. Extending our previous report (8) , 75% (54/72) of IAA-positive relatives carried a DR4 haplotype vs 20% (2/10) of IAA-negative relatives (P = 0.0004, 54/72 vs 2/10, 95% confidence interval [C.I.] = 0.02-0.4, chi square). As shown in Fig. 1 A, DR4-positive relatives had significantly higher IAA levels than DR4-negative relatives (mean = 370±70 SEM vs mean = 198±84 SEM nU/ ml; P = 0.001, rank sum test). DR4 haplotypes carrying different DRB 1 alleles (*0401, *0402, *0404, *0405) were equally associated with high IAA levels (data not shown). 18 IAA-positive individuals could be identified among 26 DR4-negative relatives. Fig. 2 for sequences).
by the linkage disequilibrium patterns among class II alleles (DR-DQ) in Caucasians (17). Analysis of DQB I subtypes among 56 DR4-positive at risk relatives revealed that 46 had the IDDM susceptibility allele DQB 1 *0302 (15, 16 ) and 11 carried the neutral allele DQB1 *0301 (8 relatives were DR4 homozygous and 2 were also DQB1 *0302/DQB1 *0301 heterozygous). However, the mean IAA level was not statistically different for these two groups of relatives (DQB 1 *0302 mean = 367±81 SEM nU/ ml, n = 46; DQB1*0301 mean = 505±166 SEM nU/ml, n = 1, P = 0.30, NS).
Since all Caucasian DR4 haplotypes carry the same allele at the DQA 1 locus (DQA 1 *0301), we compared the sequence of DQA 1*0301 with DQA1 alleles in the 18 IAA-positive relatives lacking a DR4 haplotype (Table II) . Among the seven relatives with highest IAA levels in this group, one relative carried the same DQA 1 *0301 allele usually linked to DR4 on a DR9 haplotype, and six relatives had a DQA1*01 allele (DQA1 *0102, n = 5; DQA I *0101, n = 1). Considering the whole group of 18 relatives, DQA 1 *01 alleles were found in 9 of 18 relatives (DQAl *0102, n = 8; DQA1 *0101, n = 2), and DQA 1 *0201 (associated with DR7) was present in 4 relatives.
As Fig. 2 illustrates, all the above DQA 1 alleles (DQA I *0101, *0102, *0103, *0201, *0301) derive from evolutionary lineages 1, 2, and 3 and uniquely share glutamic acid (E) at position 40 and phenylalanine (F) at position 51 (second exon) with the allele DQA1 *0301 found on DR4 haplotypes (9, 10). Therefore, we designate them DQA1 "EF" alleles. In contrast, DQA 1 alleles deriving from the evolutionary lineage 4 (DQA1 *0401, *0501, and *0601) usually not associated with high IAA levels carry glycine (G) and leucine (L) at positions 40 and 51 of the second exon (thus abbreviated as "GL" alleles).
As shown in Fig. 1 B, 70 of 82 at risk relatives (85%) carried at least one DQA1 EF allele, and 65 of these (93%) had IAA levels > 39 nU/ml (mean = 360±63 SEM nU/ml). There was no difference in the mean IAA levels between EF/GL heterozygous (mean = 300±74 SEM nU/ml) and EF/EF homozygous relatives (mean = 422±102 SEM nU/ml). In contrast, only 7 of 12 relatives homozygous for DQA1 GL alleles (Table III) EVOLUTIONARY LINEAGES 1, 2, and 3 (EF) ALLELES 
DQA1*0103:
EVOLUTIONARY LINEAGE 4 (GL) ALLELES
Residue 40 51 Figure 2 . Amino acid sequences of second exon for DQA1 EF and GL alleles. With only one exception ( 11 ), DR, DQA, and DQB patterns found in our relatives did not differ from those predicted for Caucasians ( 12) . Analysis of DQA 1 amino acid sequences of the alleles reported in Table  I , including DQA 1 *0301 allele found on DR4 haplotypes, showed that such alleles derive from the evolutionary lineages 1, 2, and 3. These alleles share glutamic acid at position 40 and phenylalanine at position 51. Therefore, they were named EF alleles. Three alleles derive from the evolutionary lineage 4. Since these alleles differ from EF alleles in that they carry glycine and leucine at positions 40 and 51, they were named GL alleles. Position 51 on the DQ a chain is located in a putative peptide-binding site. Besides positions 40 and 51, EF alleles differ from GL alleles also at positions 47, 50, and 53, where GL alleles all carry cysteine, valine, and glutamine, respectively, at these residues. Thus, the region encompassed by amino acid residues 40-53 is significantly different between the two subtypes of DQA1 alleles. quency among IAA-negative relatives (50%, 5/10) than in controls (92.9%, 53/57; P = 0.002, 95% C.I. = -0.8--0.14, Fisher's exact test). To more precisely evaluate the correlation of DQA1 subtypes with IAA levels, we subdivided our relatives into three not mutually exclusive groups according to the criteria used for the at risk definition detailed in Methods. As Table IV illustrates, the mean IAA level of relatives with DQA1 EF alleles was significantly higher than that of relatives homozygous for DQA1 GL alleles in all groups considered (relatives followed to overt IDDM, ICA-positive, and IAA-positive relatives).
DQA1*0401: -----Y-----S---------------Q-----G ----V-CL-V L RQ-R*----F--T-I--L------L---S-------DR DQA1*0501: -----Y-----S---------------Q-----G ----V-CL-V L RQ-R*----F--T-I--L-----SL---S-------DR3,DR5 DQA1*0601: S------F--------Q-----G ----V-CL-V L RQ-R*----F--T-I--T------L---S-------
In that IAA levels are inversely associated with age of diabetes diagnosis (6) , we plotted the IAA levels of our 82 relatives, subdividing them by DQA1 subtypes and age (Fig. 3) .
The markedly lower levels of IAA in those relatives homozygous for DQA1 GL alleles are apparent, consistent with the hypothesis that DQA1 GL alleles (or any gene on the haplotypes carrying such alleles) confer recessive low responsiveness to insulin.
Although the prevalence of diabetes was not significantly different in relatives with DQA1 EF or GL alleles (36 vs 50%), the mean age of diabetes diagnosis was somewhat higher in relatives with DQA 1 GL alleles (mean age = 29.9±4.6 SEM yr) than in those with DQA1 EF alleles (mean age = 18.3±3.2 SEM yr, P = 0.07, rank sum test).
Discussion
had IAA levels > 39 nU/ml (P = 0.004, 7/ 12 vs 65/70, 95% C.I. = 0.07-0.49, Fisher's exact test; mean = 55±15 SEM nU/ ml, P < 0.0001, rank sum test). Even excluding DR4-positive relatives from the calculation, those individuals with DQA 1 EF alleles (n = 14) had remarkably higher levels than those (n = 12) with GL alleles (mean = 321±147 SEM nU/ml vs mean = 55± 15 SEM nU/ml, P = 0.02, rank sum test). As shown in Fig. 1 Among other autoantibodies detectable in the serum ofprediabetics or newly diagnosed patients, IAA precede IDDM onset and correlate with rate of progression to diabetes (1) (2) (3) (4) (5) . IAA levels are usually stable during the prediabetic period (5, 6), suggesting that they may be genetically determined. Although DR4 haplotypes are strongly associated with higher levels of IAA (8), these haplotypes were not found in all relatives with high IAA levels since 18/26 (69.2%) DR4-negative relatives also had IAA levels exceeding our normal range of 39 nU/ml ( Fig. 1 B and Table II ). Based on this observation and on our analysis of DR4 DRB 1 subtypes (we could observe no difference in IAA levels among DRB1 subtypes), we suspected that DRB1 alleles on DR4 haplotypes were not primarily responsible for elevated IAA levels. Instead, our data suggested the hypothesis that genes other than DRB1 alleles on DR4 haplotypes were responsible for the association with high IAA levels and that such alleles should be common to DR4 and non-DR4 haplotypes. A candidate to improve the correlation with IAA levels was the HLA-DQ loci. These loci have been closely associated with susceptibility (15) (16) (17) (18) (19) and protection (18) tions 40 and 51 with DQAI*0301 (*0101, *0102, *0201, *0301). As shown in Fig. 2 (Fig. 2) . As Table III illustrates, only 7 of 12 relatives homozygous for GL alleles were IAA positive (P = 0.004, 7/ 12 vs 65/70 relatives with EF alleles), and only 2 of them had IAA levels > 100 nU/ml. The mean IAA level for this group was significantly lower than in relatives with EF alleles (mean = 55±15 SEM nU/ml vs mean = 360±63 SEM nU/ml, P < 0.0001). Therefore, homozygosity for DQA1 GL alleles appears to be associated with a "recessive" lack of humoral response to insulin. Moreover, relatives homozygous for DQA 1 GL alleles had lower levels of IAA at all ages in contrast to relatives with DQA1 EF alleles (Fig. 3) . The two DQA1 subtypes showed a similar correlation with IAA levels, even when we subdivided our at risk relatives according to the individual criteria used for entering the study (Table IV) . Al A similar association oflow levels ofinsulin antibodies with DR3 homozygosity has been reported previously (20) following insulin administration after diabetes onset. In agreement with the above study in IDDM patients, our findings in relatives at risk for diabetes support the hypothesis that DR3 haplotypes contain genes associated with a lack of humoral immune response to endogenous insulin and suggest an association with DQA1 sequences. The finding that a significant portion (4/ 12, 33%) of relatives homozygous for DQA1 GL alleles carried such alleles also on DR5 (DQAl*0501) and DR8 (DQA 1 *0401 ) haplotypes supports the hypothesis that DQA 1 GL alleles (and not only DQA1 *0501, DR3 haplotypes) are associated with a lack of humoral response to insulin.
Of interest, as indicated by the recently reported three-dimensional structure of a class II molecule (21 ), position 5 1 on the a chain lies within the peptide-binding site. Besides positions 40 and 51, DQA 1 EF alleles differ from GL alleles also at positions 47, 50, and 53, where GL alleles all have cysteine, valine, and glutamine, respectively, at these residues (Fig. 2) . Thus, the region encompassed by amino acid residues 40-53 is dramatically different between these two DQA1 subtypes, and we hypothesize that this may influence binding and presentation of insulin peptides. A similar association has been described recently between anticentromere autoantibodies and polar amino acids at position 26 of the HLA-DQB1 first domain (second exon) in scleroderma (22) .
In this study, relatives with DQA1 GL alleles developed diabetes at an older age (mean age = 29.9±4.6 SEM yr) than those with DQA1 EF alleles (mean age = 18.3±3.2 SEM yr, P = 0.07, rank sum test), confirming previous reports that the lack of immune response to insulin may be associated with a slower rate of the diabetogenic process (3, 6) . In conclusion, once tolerance to insulin is broken during the prediabetic phase, DQA 1 EF alleles show the strongest association (stronger than DR4) with prevalence and higher levels of IAA. Further analysis is required to address the question of whether this association is the consequence ofthe recessive lack of response mediated by DQA1 GL alleles (and DR3, DQA1 *0501 homozygosity in particular). The differences in the DQA 1 amino acid sequences discussed above may be associated with the phenotypic variation observed and support the hypothesis of two functional DQA 1 allele subsets which correlate with different levels of the humoral immune response to insulin. If confirmed by further studies, DQA1 typing may improve our ability to predict the humoral immune response to insulin and may explain a major form of phenotypic variation among prediabetic first degree relatives of patients with type I diabetes.
